MedPath

Consumption of Whole Grains and Legumes Modulates the Genetic Effect of the APOA5 -1131C Variant

Not Applicable
Completed
Conditions
Subjects With Mild Hypertriglyceridemia in Type 2 DM
Interventions
Dietary Supplement: Dietary intervention
Registration Number
NCT01784952
Lead Sponsor
Yonsei University
Brief Summary

We examined whether a substitution of whole grains and legumes for refined rice in a high carbohydrate diet (about 65% of energy derived from carbohydrate) may modify the effect of this variant on changes in apolipoprotein A-V (apoA-V) and triglyceride concentrations.

Detailed Description

We genotyped the APOA5 -1131T\>C in individuals with impaired fasting glucose (IFG) or newly diagnosed type 2 diabetes, who were randomly assigned to either a group ingesting whole grain and legume meals daily or a control group for 12 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Subjects who were in in impaired fasting glucose (IFG, 100≤ fasting glucose <126 mg/dL) and newly diagnosed type 2 diabetes (fasting glucose ≥126 mg/dL) were referred to the Department of Family Medicine or Internal Medicine. They were rechecked for their health and lipid profiles, and then those who satisfied the study criteria were recommended to participate in the dietary intervention program
Read More
Exclusion Criteria
  • Current and/or past history of cardiovascular disease including angina
  • Liver or kidney dysfunction
  • Thyroid or pituitary disease
  • Unstable weight loss/gain (≥2 kg) over the previous 6months
  • Pregnancy or lactation. Subjects who were taking medication were also excluded
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Whole grains and lequmesDietary intervention-
refined riceDietary intervention-
Primary Outcome Measures
NameTimeMethod
Triglyceridechange from baseline in TG at 12 weeks
Secondary Outcome Measures
NameTimeMethod
Apolipoprotein A5Change from baseline in ApoA5 at 12 weeks

Trial Locations

Locations (1)

Yonsei university

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath